Related Experiment Video
Updated: May 8, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Ablation of atrial fibrillation and risk of stroke: A meta-analysis
Rui Providencia1, Hussam Ali2, Sérgio Barra3
1Institute of Health Informatics Research, University College London, London, United Kingdom; Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
Insights
Catheter ablation significantly reduces stroke risk in patients with atrial fibrillation (AF) despite anticoagulant therapy. Further trials are needed to confirm this stroke protection benefit.
Area of Science:
- Cardiology
- Neurology
- Medical Interventions
Background:
- Patients with atrial fibrillation (AF) face a persistent stroke risk even with anticoagulant treatment.
- The additional stroke protection offered by catheter ablation in AF patients requires further investigation.
Purpose of the Study:
- To evaluate the stroke-protective benefits of catheter ablation for atrial fibrillation (AF).
Main Methods:
- A systematic review and meta-analysis of randomized controlled trials (RCTs) comparing catheter ablation to medical treatment in AF patients.
- Data from 18 RCTs involving 5877 patients were pooled to calculate relative risks and number needed to treat.
- Quality of evidence was assessed using GRADE, with subgroup analyses performed on various patient and study characteristics.
Main Results:
- Catheter ablation demonstrated a significant reduction in stroke risk (RR 0.63; P = .006) with a number needed to treat of 78.7.
- Moderate quality evidence showed low heterogeneity (I² = 0) across studies.
- Subgroup analyses indicated consistent stroke risk reduction, except in trials with less than one year of follow-up.
Conclusions:
- Pooled data from high-quality RCTs suggest catheter ablation offers significant stroke risk reduction in AF patients.
- While promising, a definitive answer requires a dedicated confirmatory trial.
Background:
Despite treatment with anticoagulants, patients with atrial fibrillation (AF) remain exposed to a relevant residual risk of stroke. It remains to be proven whether catheter ablation of AF can lead to an additional stroke protection benefit in these patients.
Objective:
This study aimed to investigate a possible stroke protective benefit by catheter ablation in AF.
Methods:
This is a systematic review of contemporary randomized controlled trials (RCTs) comparing catheter ablation with medical treatment. We searched MEDLINE, Embase, and Cochrane Central Register of Controlled Trials in February 2025, pooled data through relative risks (RRs) with 95% confidence intervals, and calculated the number needed to treat. Quality of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation framework. Subgroup and sensitivity analyses were performed for presence/absence of heart failure, CHA2DS2-VASc of ≥2 or <2, paroxysmal/persistent AF, early ablation, studies allowing discontinuation of oral anticoagulation after ablation, higher/lower quality, published ≤5 vs >5 years ago, and ≥12- vs <12-month follow-up.
Results:
We identified 18 eligible RCTs, including 5877 patients. Catheter ablation was associated with a significant reduction in stroke (RR 0.63, 95% confidence interval 0.45-0.87, P = .006; quality of evidence, moderate), low heterogeneity observed (I2 = 0), and a number needed to treat of 78.7 patients to prevent 1 stroke. Subgroup and sensitivity analyses yielded similar estimates with 30%-40% RR reduction for all subanalyses, except for trials with less than 1 year of follow-up.
Conclusion:
Pooling of high-quality RCT data suggests that catheter ablation may lead to significant stroke reduction. A confirmatory trial will be required to provide a conclusive answer to this matter.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests

